News

The U.S. Food and Drug Administration (FDA) has approved the medicine Xeljanz® (tofacitinib) to treat active polyarticular course JIA. This approval is for children and adolescents 2 years and older...

The U.S. Food and Drug Administration (FDA) has approved Simponi Aria® (golimumab) for the treatment of active polyarticular juvenile idiopathic arthritis in people 2 years of age and older. The...

Access to medicine is important. Drug regimens are part of treating many health conditions, and delays in taking drugs can have serious effects on health and well-being. Many people get...

Even after months of navigating life in the COVID-19 era, keeping up with new information and news can be overwhelming. Below are some of the latest developments surrounding COVID-19 for...

Many of us are overwhelmed by the amount of information available on COVID-19. Keeping up with all of the news can be challenging. Here are some of the top developments...

Our world is still changing every day because of COVID-19. Keeping up with all of the news can be challenging. Here are some of the top COVID-19 updates for people...

It is common to feel overwhelmed about COVID-19: so much information changing day-to-day. Here are some of the important COVID-19 stories that may be applicable to people living with one...

The 2020 Fatigue and Health survey has now closed. Thank you for your interest! We are excited to share the results with you soon." Exhaustion, tiredness, weariness... fatigue. We know...

As the number of cases of COVID-19 increases in the US and the world, people with rheumatic diseases are wondering if their immunosuppressants put them at greater risk of acquiring...

On March 19, the U.S. Food and Drug Administration (FDA) approved the testing of two drugs, chloroquine (hydroxychloroquine) and remdesivir, to treat people with COVID-19. The drugs have been given...

With all of the news circulating about the novel (new) coronavirus, it can be easy to feel overwhelmed or anxious. This is especially true if you are immune-compromised due to...

For those living with chronic health conditions, current news about the coronavirus (COVID-19) can be anxiety-inducing. We have questions and concerns about how the virus is transmitted, how it can...

We know the frustrations of chronic pain. Will you help others understand by taking our survey? Simply put, living with chronic pain is painful. But there is so much more...

You may have noticed that we added a new accessibility feature to our websites. This feature will allow community members to change the size, color, or contrast of the text...

Have you participated in a clinical trial? Are you interested in participating in future clinical trials? We want to hear more about your experience! Psoriatic-arthritis.com/Health Union is teaming up with...

The U.S. Food and Drug Administration (FDA) has approved Hyrimoz for the treatment of psoriatic arthritis (PsA), rheumatoid arthritis (RA), ankylosing spondylitis (AS), Crohn’s disease in adults, ulcerative colitis, plaque...

Do you feel heard by your doctor? Do your questions get answered? We want to hear from you! We’re conducting a survey to learn more about your relationship with your...

Cimzia was recently approved by the U.S. Food and Drug Administration (FDA) to treat moderate to severe plaque psoriasis. Cimzia has been previously approved to treat other inflammatory conditions, including...

Have you participated in a clinical trial? We want to hear more about your experience! We are conducting a short survey to understand how patients are involved in the clinical...

You might notice a few changes in the way things look when you visit our Psoriatic-Arthritis.com. Never fear! You still have the same tools for finding info and connecting with...